Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.021x

Based on the latest financial reports, Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) has a cash flow conversion efficiency ratio of 0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥79.81 Million ≈ $11.68 Million USD) by net assets (CN¥3.72 Billion ≈ $543.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Shandong Jincheng Pharmaceutical and Chemical Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Shandong Jincheng Pharmaceutical and Chemical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Shandong Jincheng Pharmaceutical and Che total liabilities for a breakdown of total debt and financial obligations.

Shandong Jincheng Pharmaceutical and Chemical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shandong Jincheng Pharmaceutical and Chemical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Group Up Industrial Co Ltd
TWO:6664
0.027x
MannKind Corp
NASDAQ:MNKD
-0.527x
Hyundai Bioscience Co. Ltd
KQ:048410
-0.032x
Tangrenshen Group Co Ltd
SHE:002567
0.028x
Southside Bancshares, Inc.
NASDAQ:SBSI
0.048x
Aoyuan Beauty Valley Technology Co Ltd
SHE:000615
0.035x
Service Stream Ltd
AU:SSM
0.101x
KRN Heat Exchanger and Refrigeration
NSE:KRN
N/A

Annual Cash Flow Conversion Efficiency for Shandong Jincheng Pharmaceutical and Chemical Co Ltd (2008–2024)

The table below shows the annual cash flow conversion efficiency of Shandong Jincheng Pharmaceutical and Chemical Co Ltd from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Shandong Jincheng Pharmaceutical and Che.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥3.83 Billion
≈ $560.76 Million
CN¥296.59 Million
≈ $43.40 Million
0.077x -55.93%
2023-12-31 CN¥3.78 Billion
≈ $553.29 Million
CN¥664.08 Million
≈ $97.18 Million
0.176x +151.42%
2022-12-31 CN¥3.66 Billion
≈ $535.47 Million
CN¥255.63 Million
≈ $37.41 Million
0.070x -45.04%
2021-12-31 CN¥3.44 Billion
≈ $503.30 Million
CN¥437.19 Million
≈ $63.97 Million
0.127x -19.30%
2020-12-31 CN¥3.47 Billion
≈ $507.37 Million
CN¥546.13 Million
≈ $79.92 Million
0.158x +11.32%
2019-12-31 CN¥4.08 Billion
≈ $597.74 Million
CN¥577.98 Million
≈ $84.58 Million
0.141x +64.24%
2018-12-31 CN¥4.09 Billion
≈ $598.21 Million
CN¥352.20 Million
≈ $51.54 Million
0.086x +123.44%
2017-12-31 CN¥3.94 Billion
≈ $576.20 Million
CN¥151.83 Million
≈ $22.22 Million
0.039x -75.98%
2016-12-31 CN¥1.50 Billion
≈ $220.11 Million
CN¥241.48 Million
≈ $35.34 Million
0.161x +1.17%
2015-12-31 CN¥1.31 Billion
≈ $191.74 Million
CN¥207.92 Million
≈ $30.42 Million
0.159x -19.26%
2014-12-31 CN¥1.12 Billion
≈ $163.40 Million
CN¥219.46 Million
≈ $32.11 Million
0.197x +113.78%
2013-12-31 CN¥1.02 Billion
≈ $149.51 Million
CN¥93.92 Million
≈ $13.74 Million
0.092x +3.55%
2012-12-31 CN¥975.57 Million
≈ $142.76 Million
CN¥86.61 Million
≈ $12.67 Million
0.089x +35.78%
2011-12-31 CN¥958.84 Million
≈ $140.31 Million
CN¥62.69 Million
≈ $9.17 Million
0.065x -77.42%
2010-12-31 CN¥375.33 Million
≈ $54.92 Million
CN¥108.67 Million
≈ $15.90 Million
0.290x -22.83%
2009-12-31 CN¥281.53 Million
≈ $41.20 Million
CN¥105.62 Million
≈ $15.46 Million
0.375x +168.69%
2008-12-31 CN¥216.49 Million
≈ $31.68 Million
CN¥30.23 Million
≈ $4.42 Million
0.140x --

About Shandong Jincheng Pharmaceutical and Chemical Co Ltd

SHE:300233 China Chemicals
Market Cap
$871.80 Million
CN¥5.96 Billion CNY
Market Cap Rank
#9740 Global
#2739 in China
Share Price
CN¥15.52
Change (1 day)
-0.77%
52-Week Range
CN¥13.85 - CN¥21.36
All Time High
CN¥40.87
About

Shandong Jincheng Pharmaceutical Group Co., Ltd researches and develops, produces, markets, and sells Cephalosporin intermediates in China and internationally. It offers medical intermediate, animal nutrition, health care, CMO, CDMO, pharmaceuticals, API, finished dosage, and fine chemicals. Shandong Jincheng Pharmaceutical Group Co., Ltd was founded in 2004 and is based in Zibo, China.